Paul Zolkind

1.1k total citations
33 papers, 440 citations indexed

About

Paul Zolkind is a scholar working on Oncology, Otorhinolaryngology and Molecular Biology. According to data from OpenAlex, Paul Zolkind has authored 33 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Otorhinolaryngology and 14 papers in Molecular Biology. Recurrent topics in Paul Zolkind's work include Head and Neck Cancer Studies (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Diagnosis and Treatment (5 papers). Paul Zolkind is often cited by papers focused on Head and Neck Cancer Studies (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cancer Diagnosis and Treatment (5 papers). Paul Zolkind collaborates with scholars based in United States, Ireland and China. Paul Zolkind's co-authors include Ravindra Uppaluri, Douglas R. Adkins, Tianxiang Lin, Gavin P. Dunn, Patrik Pipkorn, Glenn J. Hanna, Ryan S. Jackson, Malachi Griffith, Rebecca D. Chernock and Jason T. Rich and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Paul Zolkind

27 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Zolkind United States 13 295 136 134 114 102 33 440
Francesca Sparano Italy 9 219 0.7× 78 0.6× 113 0.8× 51 0.4× 103 1.0× 19 369
Marc Lucas Ooft Netherlands 6 295 1.0× 186 1.4× 102 0.8× 76 0.7× 62 0.6× 7 396
Ravindra Uppaluri United States 10 313 1.1× 390 2.9× 159 1.2× 45 0.4× 44 0.4× 25 590
Shiau-Chin Liu Taiwan 8 147 0.5× 99 0.7× 188 1.4× 38 0.3× 34 0.3× 8 355
Patrick Chun United States 9 243 0.8× 73 0.5× 142 1.1× 22 0.2× 101 1.0× 19 364
Monique C. de Jong Netherlands 11 159 0.5× 23 0.2× 191 1.4× 121 1.1× 105 1.0× 13 443
Yae‐Eun Suh United Kingdom 9 117 0.4× 25 0.2× 188 1.4× 107 0.9× 98 1.0× 16 389
Frank Ziemann Germany 8 113 0.4× 23 0.2× 121 0.9× 102 0.9× 57 0.6× 10 259
Shereen Rafee Ireland 8 148 0.5× 38 0.3× 161 1.2× 16 0.1× 76 0.7× 15 328
Yixin Liu China 9 173 0.6× 104 0.8× 158 1.2× 10 0.1× 46 0.5× 25 362

Countries citing papers authored by Paul Zolkind

Since Specialization
Citations

This map shows the geographic impact of Paul Zolkind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Zolkind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Zolkind more than expected).

Fields of papers citing papers by Paul Zolkind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Zolkind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Zolkind. The network helps show where Paul Zolkind may publish in the future.

Co-authorship network of co-authors of Paul Zolkind

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Zolkind. A scholar is included among the top collaborators of Paul Zolkind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Zolkind. Paul Zolkind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterson, Andrew M., Dorina Kallogjeri, Katherine W. Chang, et al.. (2025). Unilateral vs Bilateral Transoral Robotic Surgery for HPV-Positive Tonsillar Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 151(12). 1157–1157.
2.
Walia, Amit, Jake J. Lee, R. Alex Harbison, et al.. (2025). Predictors and Implications of Bony Union of Osseous Free Flaps for Oromandibular Reconstruction. Head & Neck. 47(11). 3058–3067.
3.
Barrett, Thomas F., Anthony J. Apicelli, Patrik Pipkorn, et al.. (2025). Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalation. Oral Oncology. 169. 107631–107631.
4.
Neal, Molly E. Heft, Wade L. Thorstad, Hiram A. Gay, et al.. (2025). Long‐Term Outcomes After Elective Contralateral Neck Dissection for HPV‐Related Oropharyngeal Cancer. Otolaryngology. 172(6). 1954–1961.
5.
Puram, Sidharth V., Randal C. Paniello, Patrik Pipkorn, et al.. (2025). Patient‐Reported Swallowing Outcomes in HPV+ Oropharyngeal Cancer by Postoperative Chemoradiation Dose in MINT and E3311. Otolaryngology. 173(2). 410–419. 2 indexed citations
6.
Al‐Qurayshi, Zaid, Katherine W. Chang, Paul Zolkind, et al.. (2025). Use of Intraoperative Frozen Section to Assess Surgical Margins in HPV-Related Oropharyngeal Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 151(3). 253–253. 2 indexed citations
7.
Al‐Qurayshi, Zaid, Jason T. Rich, R. Alex Harbison, et al.. (2024). Trends in incidence of oral cavity squamous cell carcinoma in the United States 2001-2019. 1(2). 100055–100055.
8.
Hamad, Samera H., Rani S. Sellers, Paul Zolkind, et al.. (2024). NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma. Cancer Research Communications. 4(2). 487–495. 4 indexed citations
9.
Lee, Jake J., Ray Wang, Ryan S. Jackson, et al.. (2023). Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers. Oral Oncology. 147. 106607–106607. 5 indexed citations
10.
Wilkerson, Emily, Li Guan, Kyle M. LaPak, et al.. (2023). Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC. Molecular & Cellular Proteomics. 22(11). 100647–100647. 15 indexed citations
11.
Massa, Sean T., Paul Zolkind, Randal C. Paniello, et al.. (2023). Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma. Cancer Medicine. 12(8). 9976–9987. 4 indexed citations
12.
Parikh, Anuraag S., Yize Li, Angela L. Mazul, et al.. (2023). Immune Cell Deconvolution Reveals Possible Association of γδ T Cells with Poor Survival in Head and Neck Squamous Cell Carcinoma. Cancers. 15(19). 4855–4855. 3 indexed citations
13.
Zolkind, Paul, Ricardo J. Ramirez, Zachary L. Skidmore, et al.. (2022). Integrative genomic analysis reveals low T-cell infiltration as the primary feature of tobacco use in HPV-positive oropharyngeal cancer. iScience. 25(5). 104216–104216. 8 indexed citations
14.
Mudianto, Tenny, Katie M. Campbell, Jason A. Webb, et al.. (2021). Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas. Clinical Cancer Research. 27(8). 2326–2339. 18 indexed citations
15.
Pipkorn, Patrik, et al.. (2020). Negative-Pressure Aerosol Cover for COVID-19 Tracheostomy. JAMA Otolaryngology–Head & Neck Surgery. 146(7). 672–672. 24 indexed citations
16.
Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations
17.
Campbell, Katie M., Tianxiang Lin, Paul Zolkind, et al.. (2018). Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity. Cell Reports. 24(8). 2167–2178. 23 indexed citations
18.
Hanna, Glenn J., Douglas R. Adkins, Paul Zolkind, & Ravindra Uppaluri. (2017). Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma. Oral Oncology. 73. 65–69. 35 indexed citations
19.
Zolkind, Paul & Ravindra Uppaluri. (2017). Checkpoint immunotherapy in head and neck cancers. Cancer and Metastasis Reviews. 36(3). 475–489. 35 indexed citations
20.
Fenelus, Maly, Abhishek Sarkar, Paul Zolkind, et al.. (2014). The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.. PubMed. 44(3). 241–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Sparano Breakdown of academic impact, for papers by Marc Lucas Ooft Breakdown of academic impact, for papers by Ravindra Uppaluri Breakdown of academic impact, for papers by Shiau-Chin Liu Breakdown of academic impact, for papers by Patrick Chun Breakdown of academic impact, for papers by Monique C. de Jong Breakdown of academic impact, for papers by Yae‐Eun Suh Breakdown of academic impact, for papers by Frank Ziemann Breakdown of academic impact, for papers by Shereen Rafee Breakdown of academic impact, for papers by Yixin Liu
Rankless by CCL
2026